Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells

S Kojima, K Nara, D B Rifkin, S Kojima, K Nara, D B Rifkin

Abstract

A hitherto unknown function for transglutaminase (TGase; R-glutaminyl-peptide: amine gamma-glutamyltransferase, EC 2.3.2.13) was found in the conversion of latent transforming growth factor-beta (LTGF-beta) to active TGF-beta by bovine aortic endothelial cells (BAECs). The cell-associated, plasmin-mediated activation of LTGF-beta to TGF-beta induced either by treatment of BAECs with retinoids or by cocultures of BAECs and bovine smooth muscle cells (BSMCs) was blocked by seven different inhibitors of TGase as well as a neutralizing antibody to bovine endothelial cell type II TGase. Control experiments indicated that TGase inhibitors and/or a neutralizing antibody to TGase did not interfere with the direct action of TGF-beta, the release of LTGF-beta from cells, or the activation of LTGF-beta by plasmin or by transient acidification. After treatment with retinoids, BAECs expressed increased levels of TGase coordinate with the generation of TGF-beta, whereas BSMCs and bovine embryonic skin fibroblasts, which did not activate LTGF-beta after treatment with retinoids, did not. Furthermore, both TGase inhibitors and a neutralizing antibody to TGase potentiated the effect of retinol in enhancing plasminogen activator (PA) levels in cultures of BAECs by suppressing the TGF-beta-mediated enhancement of PA inhibitor-1 (PAI-1) expression. These results indicate that type II TGase is a component required for cell surface, plasmin-mediated LTGF-beta activation process and that increased expression of TGase accompanies retinoid-induced activation of LTGF-beta.

References

    1. J Biol Chem. 1991 Jan 15;266(2):1101-8
    1. Science. 1986 Sep 5;233(4768):1078-80
    1. Biochem Biophys Res Commun. 1991 Jan 31;174(2):465-9
    1. Ann N Y Acad Sci. 1991;614:250-8
    1. J Cell Biol. 1991 Jun;113(6):1439-45
    1. Thromb Haemost. 1991 May 6;65(5):565-72
    1. Biochemistry. 1987 Jan 13;26(1):308-13
    1. Blood. 1987 Sep;70(3):702-9
    1. J Cell Biol. 1987 Aug;105(2):957-63
    1. J Cell Biol. 1988 May;106(5):1659-65
    1. Biol Chem Hoppe Seyler. 1988 Apr;369(4):275-81
    1. Biochemistry. 1988 Apr 19;27(8):2898-905
    1. J Cell Physiol. 1989 Jan;138(1):79-86
    1. Biochem Biophys Res Commun. 1989 Feb 15;158(3):817-23
    1. J Cell Biochem. 1989 Mar;39(3):293-304
    1. Proc Natl Acad Sci U S A. 1989 Jun;86(12):4544-8
    1. J Cell Biol. 1989 Jul;109(1):309-15
    1. Biochem Biophys Res Commun. 1989 Aug 15;162(3):1370-5
    1. Biochem J. 1989 Sep 1;262(2):633-41
    1. J Biol Chem. 1989 Nov 15;264(32):19308-12
    1. J Biol Chem. 1989 Dec 5;264(34):20502-8
    1. J Cell Biol. 1990 Apr;110(4):1361-7
    1. Cell. 1990 Jun 15;61(6):1051-61
    1. J Biol Chem. 1990 Jul 5;265(19):11098-104
    1. Biochim Biophys Acta. 1990 Jun 1;1032(1):79-87
    1. J Cell Biol. 1990 Aug;111(2):757-63
    1. J Biol Chem. 1990 Oct 5;265(28):17180-8
    1. J Biol Chem. 1990 Oct 15;265(29):17891-8
    1. Cancer Res. 1990 Dec 15;50(24):7830-4
    1. Growth Factors. 1990;3(4):277-86
    1. J Clin Invest. 1991 Jan;87(1):148-54
    1. J Clin Invest. 1991 Jan;87(1):277-83
    1. J Biol Chem. 1991 Jan 5;266(1):478-83
    1. Eur J Biochem. 1991 Nov 15;202(1):15-21
    1. J Biol Chem. 1991 Nov 25;266(33):22501-9
    1. FASEB J. 1991 Dec;5(15):3071-7
    1. J Cell Physiol. 1991 Dec;149(3):375-82
    1. Cell Regul. 1989 Nov;1(1):87-97
    1. J Cell Physiol. 1992 Jul;152(1):48-55
    1. J Cell Biol. 1993 Feb;120(4):995-1002
    1. Ann N Y Acad Sci. 1978 Jun 20;312:354-65
    1. Proc Natl Acad Sci U S A. 1979 Nov;76(11):5731-5
    1. Biochim Biophys Acta. 1980 Jul 15;630(4):476-84
    1. Annu Rev Biochem. 1980;49:517-31
    1. J Cell Biol. 1982 Dec;95(3):974-81
    1. Mol Cell Biochem. 1984;58(1-2):9-35
    1. Anal Biochem. 1984 Mar;137(2):454-63
    1. J Biol Chem. 1985 Feb 10;260(3):1422-6
    1. Cell. 1985 Mar;40(3):685-95
    1. Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):580-4

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다